WallStSmart

Cigna Corp (CI)vsElevance Health Inc (ELV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cigna Corp generates 40% more annual revenue ($282.38B vs $201.11B). ELV leads profitability with a 2.5% profit margin vs 2.3%. CI appears more attractively valued with a PEG of 0.76. CI earns a higher WallStSmart Score of 67/100 (B-).

CI

Strong Buy

67

out of 100

Grade: B-

Growth: 6.7Profit: 5.5Value: 9.3Quality: 5.5
Piotroski: 5/9Altman Z: 2.50

ELV

Buy

52

out of 100

Grade: C-

Growth: 4.0Profit: 5.0Value: 5.3Quality: 7.0
Piotroski: 4/9Altman Z: 2.66
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CIUndervalued (+58.5%)

Margin of Safety

+58.5%

Fair Value

$676.72

Current Price

$280.76

$395.96 discount

UndervaluedFair: $676.72Overvalued
ELVFair Value (-0.7%)

Margin of Safety

-0.7%

Fair Value

$415.84

Current Price

$418.72

$2.88 premium

UndervaluedFair: $415.84Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CI4 strengths · Avg: 8.8/10
P/E RatioValuation
11.6x10/10

Attractively priced relative to earnings

Market CapQuality
$74.19B9/10

Large-cap with strong market position

PEG RatioValuation
0.768/10

Growing faster than its price suggests

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

ELV3 strengths · Avg: 8.3/10
Market CapQuality
$90.81B9/10

Large-cap with strong market position

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.63B8/10

Generating 1.6B in free cash flow

Areas to Watch

CI3 concerns · Avg: 2.7/10
Profit MarginProfitability
2.3%3/10

2.3% margin — thin

Operating MarginProfitability
4.0%3/10

Operating margin of 4.0%

Free Cash FlowQuality
$-718.00M2/10

Negative free cash flow — burning cash

ELV4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
1.4%4/10

1.4% revenue growth

Profit MarginProfitability
2.5%3/10

2.5% margin — thin

Operating MarginProfitability
4.6%3/10

Operating margin of 4.6%

EPS GrowthGrowth
-13.1%2/10

Earnings declined 13.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : CI

The strongest argument for CI centers on P/E Ratio, Market Cap, PEG Ratio. PEG of 0.76 suggests the stock is reasonably priced for its growth.

Bull Case : ELV

The strongest argument for ELV centers on Market Cap, Price/Book, Free Cash Flow. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bear Case : CI

The primary concerns for CI are Profit Margin, Operating Margin, Free Cash Flow. Thin 2.3% margins leave little buffer for downturns.

Bear Case : ELV

The primary concerns for ELV are Revenue Growth, Profit Margin, Operating Margin. Thin 2.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

ELV carries more volatility with a beta of 0.70 — expect wider price swings.

CI is growing revenue faster at 6.7% — sustainability is the question.

ELV generates stronger free cash flow (1.6B), providing more financial flexibility.

Monitor HEALTHCARE PLANS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CI scores higher overall (67/100 vs 52/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cigna Corp

HEALTHCARE · HEALTHCARE PLANS · USA

Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).

Visit Website →

Elevance Health Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Want to dig deeper into these stocks?